Showing results (311-320 of 602) with videos related to

Sort By:
Pageof 61
Mayo Clinic Proceedings|January 7, 2014
Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patientsJames T McCarthy, Craig L Hocum, Robert C Albright, et al.
Nature Communications|August 8, 2018
A PDGFRα-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastineHyun Jung Jun, Vicky A Appleman, Hua-Jun Wu, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 14, 2018
Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?Eli Muchtar, Morie A Gertz, Shaji K Kumar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 12, 2018
Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain AmyloidosisM Hasib Sidiqi, Francis K Buadi, Angela Dispenzieri, et al.
Blood|July 19, 2013
Implications of continued response after autologous stem cell transplantation for multiple myelomaWilson I Gonsalves, Morie A Gertz, Angela Dispenzieri, et al.
American Journal of Hematology|June 12, 2016
Proteasome inhibitor associated thrombotic microangiopathyJennifer C Yui, Jan Van Keer, Brendan M Weiss, et al.
The Journal of Clinical Investigation|September 21, 2023
A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progressionZhihong Chen, Bruno Giotti, Milota Kaluzova, et al.
Research Square|November 14, 2023
Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patientsS Rajkumar, Nadine Abdallah, Arjun Lakshman, et al.
Bone Marrow Transplantation|December 4, 2020
Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agentsIuliana Vaxman, Alissa Visram, Shaji Kumar, et al.
Haematologica|June 5, 2013
A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?Nelson Leung, Siobhan V Glavey, Shaji Kumar, et al.
Pageof 61